Live Breaking News & Updates on Pulmonx Corporation

Stay updated with breaking news from Pulmonx corporation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Insider Selling: Pulmonx Co. (NASDAQ:LUNG) CEO Sells $126,800.00 in Stock

Pulmonx Co. (NASDAQ:LUNG – Get Rating) CEO Glendon E. French III sold 10,000 shares of the company’s stock in a transaction on Thursday, June 15th. The shares were sold at an average price of $12.68, for a total transaction of $126,800.00. Following the completion of the sale, the chief executive officer now directly owns 1,189,547 […] ....

Piper Sandler , Wells Fargo Company , Pulmonx Company Profile , Canaccord Genuity Group , Pulmonx Corporation , Goldman Sachs Group Inc , Morgan Stanley , Pulmonx Co , Get Rating , Genuity Group , Goldman Sachs Group , Sachs Group , Zephyr Endobronchial Valve , Chartis Pulmonary Assessment System , Pulmonx Daily ,

Glendon E. French III Sells 10,000 Shares of Pulmonx Co. (NASDAQ:LUNG) Stock

Pulmonx Co. (NASDAQ:LUNG – Get Rating) CEO Glendon E. French III sold 10,000 shares of Pulmonx stock in a transaction on Thursday, June 15th. The stock was sold at an average price of $12.68, for a total value of $126,800.00. Following the sale, the chief executive officer now owns 1,189,547 shares of the company’s stock, […] ....

Piper Sandler , Denali Advisors , Securities Exchange Commission , Morgan Stanley , Canaccord Genuity Group , Pulmonx Corporation , Primecap Management Co , Wells Fargo Company , Pulmonx Co , Pulmonx Company Profile , Get Rating , Exchange Commission , Genuity Group , Zephyr Endobronchial Valve , Chartis Pulmonary Assessment System , Pulmonx Daily , Nasdaq Lung , Insider Trading , Nsider Trades ,

Pulmonx (NASDAQ:LUNG) Shares Up 5.8%

Pulmonx Co. (NASDAQ:LUNG – Get Rating)’s share price shot up 5.8% on Tuesday . The company traded as high as $13.50 and last traded at $13.35. 91,942 shares were traded during trading, a decline of 78% from the average session volume of 417,824 shares. The stock had previously closed at $12.62. Analyst Upgrades and Downgrades […] ....

Piper Sandler , Pulmonx Company Profile , Morgan Stanley , Wells Fargo Company , Jpmorgan Chase Co , Pulmonx Corporation , Geode Capital Management , Pulmonx Co , Canaccord Genuity Group , Get Rating , Genuity Group , Street Corp , Capital Management , Sigma Advisers , Two Sigma Investments , Sigma Investments , Zephyr Endobronchial Valve , Chartis Pulmonary Assessment System , Pulmonx Daily ,

Denali Advisors LLC Buys Shares of 7,400 Pulmonx Co. (NASDAQ:LUNG)

Denali Advisors LLC acquired a new position in shares of Pulmonx Co. (NASDAQ:LUNG – Get Rating) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 7,400 shares of the company’s stock, valued at approximately $62,000. Several other institutional investors and hedge funds have also made […] ....

Piper Sandler , Securities Exchange Commission , Denali Advisors , Morgan Stanley , Canaccord Genuity Group , Wells Fargo Company , Pulmonx Corporation , Pulmonx Co , Wealth Partners , Goldman Sachs Group Inc , Health Sciences , Get Rating , Sachs Group , Capital World Investors , World Investors , Zephyr Endobronchial Valve , Chartis Pulmonary Assessment System , Pulmonx Daily , Nasdaq Lung , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Pulmonx Co. (NASDAQ:LUNG) Given Average Recommendation of "Moderate Buy" by Brokerages

Pulmonx Co. (NASDAQ:LUNG – Get Rating) has been given an average recommendation of “Moderate Buy” by the eight research firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have assigned a buy recommendation to the company. The […] ....

Hong Kong , Piper Sandler , Banque Cantonale Vaudoise , Canaccord Genuity Group , Us Bancorp , Pulmonx Co , Denali Advisors , Wells Fargo Company , Ensign Peak Advisors Inc , Hong Kong Ltd , Securities Exchange Commission , Pulmonx Corporation , Morgan Stanley , Get Rating , Exchange Commission , Kong Ltd , Peak Advisors Inc , Cantonale Vaudoise , Zephyr Endobronchial Valve , Chartis Pulmonary Assessment System , Pulmonx Daily , Nasdaq Lung ,